Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer

Prostate

Volumn 36, Issue 2, 1998, Pages 85-91

  Pilarsky, Christian P ^a   Schmidt, Uta ^a   Eißrich, Claudia ^a   Stade, Jörg ^a   Froschermaier, Stefan E ^a   Haase, Michael ^a   Faller, Gerhard ^b   Kirchner, Thomas W ^b   Wirth, Manfred P ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Cyr61; Differential display PCR; Prostate

Indexed keywords

DNA FRAGMENT;

ARTICLE; ENERGY METABOLISM; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMEDIATE EARLY GENE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; RNA ANALYSIS; SIGNAL TRANSDUCTION; TUMOR DIAGNOSIS; TUMOR GROWTH;

ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RNA-DIRECTED DNA POLYMERASE; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0031862238     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980701)36:2<85::AID-PROS3>3.0.CO;2-D     Document Type: Article

References (20)

1. Shen R, Su ZZ, Olsson CA, Fisher PB: Identification of the human prostatic carcinoma oncogene PTI-by rapid expression cloning and differential RNA display. Proc Natl Acad Sci USA 1995;92:6778-6782.
2. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275: 1943-1947.
3. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP: In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995;9:401-406.
4. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM, Isaacs WB: Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996;274:1371-1374.
5. Blok LJ, Grossmann ME, Perry JE, Tindall DJ: Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. Mol Endocrinol 1995;9:1610-1620.
6. Thigpen AE, Cala KM, Guileyardo JM, Molberg KH, McConnell JD, Russel DW: Increased expression of early growth response-1 messenger ribonucleic acid in prostatic adenocarcinoma. J Urol 1996;155:975-981.
7. Wang FL, Wang Y, Wong WK, Liu Y, Addivinola FJ, Liang P, Chen LB, Kantoff PW, Pardee AB: Two differentially expressed genes in normal human prostate tissue and in carcinoma. Cancer Res 1996;56:3634-3637.
8. Van G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan WL: Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 1993;13:4513-4522.
9. Peehl DM, Rubin JS: Keratinocyte growth factor: An androgen-regulated mediator of stromal-epithelial interactions in the prostate. World J Urol 1995;13:312-317.
10. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Hittmair A, Zhang J, Thurnher M, Bartsch G, Klocker H: Regulation of prostatic growth and function by peptide growth factors. Prostate 1996;28:392-405.
11. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992;257:967-971.
12. Jay P, Berge-Lefranc JL, Marsollier C, Mejean C, Taviaux S, Berta P: The human growth factor-inducible immediate early gene, CYR61, maps to chromosome 1p. Oncogene 1997;14:1753-1757.
13. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
14. Yang GP, Lau LF: Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Differ 1991;2:351-357.
15. Panoskaltsis-Mortari A, Bucy RP: In situ hybridization with digoxigenin-labeled RNA probes: Facts and artifacts. Biotechniques 1995;18:300-307.
16. Callard D, Lescure B, Mazzolini L: A method for the elimination of false positives generated by the mRNA differential display technique. Biotechniques 1994;16:1096-1097.
17. Kireeva ML, Mo FE, Yang GP, Lau LF: Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol 1996;16: 1326-1334.
18. Kireeva ML, Latinkic BV, Kolesnikova TV, Chen CC, Yang GP, Abler AS, Lau LF: Cyr61 and Fisp12 are both ECM-associated signaling molecules: Activities, metabolism, and localization during development. Exp Cell Res 1997;233:63-77.
19. Mathew S, Murty VV, Bosl GJ, Chaganti RS: Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res 1994;54: 6265-6269.
20. Lee WC, Balsara B, Liu Z, Jhanwar SC, Testa JR: Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma. Cancer Res 1996;56:4297-4301.